End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30 TWD | -2.12% | +12.99% | +0.84% |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody New Drug
100.0
%
| 30 | 100.0 % | 3 | 100.0 % | -91.55% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
63.3
%
| 19 | 64.1 % | 2 | 63.3 % | -91.65% |
Taiwan
36.7
%
| 0 | 1.6 % | 1 | 36.7 % | +99.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mei Chun Yang
CEO | Chief Executive Officer | - | 06-12-31 |
Tong Hsuan Chang
FOU | Founder | - | 01-01-31 |
Dih Fen Wu
DFI | Director of Finance/CFO | - | 09-12-31 |
Yao Hua Lue
IRC | Investor Relations Contact | - | 12-11-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kao Chung Tsai
BRD | Director/Board Member | 62 | - |
Tong Hsuan Chang
FOU | Founder | - | 01-01-31 |
Ling-Chun Tsai
BRD | Director/Board Member | - | 12-05-24 |
Hsiu E. Su
BRD | Director/Board Member | - | - |
Tseng-Fu Chen
BRD | Director/Board Member | - | 12-05-24 |
Cai Qing Hong
BRD | Director/Board Member | - | - |
Zong Zheng Wu
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 108,640,100 | 89,098,133 ( 82.01 %) | 0 | 82.01 % |
Company contact information
GlycoNex, Inc.
8th Floor, Section 1 No. 97 Xintai 5th Road
221 75, New Taipei
+
http://www.glyconex.com.twSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+0.84% | 100M | |
+39.27% | 39.1B | |
-7.51% | 38.76B | |
+27.16% | 31.24B | |
+12.68% | 25.9B | |
-13.75% | 25.8B | |
+45.79% | 14.06B | |
+40.37% | 13.12B | |
-6.00% | 11.32B | |
-11.46% | 10.68B |
- Stock Market
- Equities
- 4168 Stock
- Company GlycoNex Incorporation